Merck KGaA (XTER:MRK)
€ 155.5 -0.2 (-0.13%) Market Cap: 67.61 Bil Enterprise Value: 75.46 Bil PE Ratio: 23.96 PB Ratio: 2.53 GF Score: 89/100

Merck KGaA at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 07:15PM GMT
Release Date Price: €201.1 (+4.47%)
Richard Vosser
JPMorgan Chase & Co, Research Division - Senior Analyst

Welcome to the Merck KGaA from Darmstadt Germany presentation at the 41st JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. And it's my great pleasure to introduce the CEO of Merck KGaA, Belen Garijo, but before I hand over to Belen, I would just remind you that we're staying here for questions first time. And we will do them using a mic, so please put your hand up and we'll get to your questions after Belen's presentation. Belen, welcome to the conference.

Belen Garijo Lopez
MERCK Kommanditgesellschaft auf Aktien - Chair of Executive Board & CEO

Thank you so much, Richard, for the introduction. And good morning, everyone. Happy new year to all of you. I'm super excited to be here in person, finally, after several years of virtuality, as we call it, so what I would like to do during the next 20 minutes is to take you through a brief strategy update as well as give you a bit additional information and additional color on our two major business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot